<DOC>
	<DOCNO>NCT00676936</DOCNO>
	<brief_summary>Study hypothesis : corticosteroid effective pain cancer patient . We perform double-blind , randomize , placebo-controlled multicentre trial evaluate effect Methylprednisolone 16 mg twice daily cancer patient pain ( average pain last 24 hr NRS &gt; 4 ( Numerical rating scale , 0 No pain , 10 bad pain ) .</brief_summary>
	<brief_title>Corticosteroids Cancer Pain</brief_title>
	<detailed_description>Patients require use strong opioids enter study . Weak opioids allow patient short act strong opioids rescue-medication . The scheduled opioids shall stable last 48 hour enter study keep stable study period . Patients may use much short act rescue-medication require . No analgesic medication start study period . The study multicentre trial . Patients randomize accord 1. study centre ( No 1-5 ) 2. pain mechanism : skeletal metastasis ( yes/no ) . Patients evaluate Day 0 Day 7 palliative care physician . Patients contact phone Day 1-6 fill questionnaire regard symptom analgesic usage . Patients contact Day 14 21 fill questionnaire regard symptom , quality life side effect .</detailed_description>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Verified malignant disease Receiving schedule strong weak opioid Insufficient pain control : Average pain last 24 h : ≥ 4 ( NRS 010 ) Given informed consent accord ethical guideline Able complete plan assessment schedule ≥ 18 year age Life expectancy &gt; 1 month Excruciating pain ( average pain ≥ 8 ) ( These patient consider emergency patient . Patients may eligible study stabilization ) Dose adjustment schedule opioid medication last 48 hour Concurrent medication NSAIDs ( Patients eligible study one week NSAIDs discontinue ) Receiving radiotherapy within 4 week enter study plan within study period Started systemic treatment ( chemotherapy , hormone therapy bisphosphonates ) within 4 week enter study Patients receive chemotherapy 4 week eligible study 7 day since receive last dose next dose within study period Manifest spinal cord compression need bone surgery Severe cognitive impairment Previously steroids last 4 week Diabetes mellitus Known peptic ulcer disease Systemic fungal disease , patient vaccinate viable virus , patient know allergy study medication ( MethylPrednisolone ) Female patient pregnant lactate . Women reproductive potential willing unable employ effective method contraception ( sterilize , use IUD oral contraception ) Patients use follow medication : cyclosporin , erythromycin , phenobarbital , phenytoin , carbamazepin , ketoconazole , methotrexate , ciclofosfamide , rifampicin , aprepitant diltiazem .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Cancer</keyword>
	<keyword>pain</keyword>
	<keyword>corticosteroid</keyword>
	<keyword>palliative</keyword>
	<keyword>supportive care</keyword>
	<keyword>Cancer patient pain</keyword>
</DOC>